BCC-NER: bidirectional, contextual clues named entity tagger for gene/protein mention recognition

Dictionary-based matching graph network for biomedical named entity recognition

Biomedical named entity recognition (BioNER) is an essential task in biomedical information analysis. Recently, deep neural approaches have become widely utilized for BioNER. Biomedical dictionaries, implemented through a masked manner, are frequently employed in these methods to enhance entity recognition. However, their performance remains limited. In this work, we propose a dictionary-based matching graph network for BioNER. This approach utilizes the matching graph method to project all possible dictionary-based entity combinations in the text onto a directional graph. The network is implemented coherently with a bi-directional graph convolutional network (BiGCN) that incorporates the matching graph information. Our proposed approach fully leverages the dictionary-based matching graph instead of a simple masked manner. We have conducted numerous experiments on five typical Bio-NER datasets. The proposed model shows significant improvements in F1 score compared to the state-of-the-art (SOTA) models: 2.8% on BC2GM, 1.3% on BC4CHEMD, 1.1% on BC5CDR, 1.6% on NCBI-disease, and 0.5% on JNLPBA. The results show that our model, which is superior to other models, can effectively recognize natural biomedical named entities.

Artificial Intelligence and Cardiovascular Genetics

Polygenic diseases, which are genetic disorders caused by the combined action of multiple genes, pose unique and significant challenges for the diagnosis and management of affected patients. A major goal of cardiovascular medicine has been to understand how genetic variation leads to the clinical heterogeneity seen in polygenic cardiovascular diseases (CVDs). Recent advances and emerging technologies in artificial intelligence (AI), coupled with the ever-increasing availability of next generation sequencing (NGS) technologies, now provide researchers with unprecedented possibilities for dynamic and complex biological genomic analyses. Combining these technologies may lead to a deeper understanding of heterogeneous polygenic CVDs, better prognostic guidance, and, ultimately, greater personalized medicine. Advances will likely be achieved through increasingly frequent and robust genomic characterization of patients, as well the integration of genomic data with other clinical data, such as cardiac imaging, coronary angiography, and clinical biomarkers. This review discusses the current opportunities and limitations of genomics; provides a brief overview of AI; and identifies the current applications, limitations, and future directions of AI in genomics.

Combining Literature Mining and Machine Learning for Predicting Biomedical Discoveries

The major outcomes and insights of scientific research and clinical study end up in the form of publication or clinical record in an unstructured text format. Due to advancements in biomedical research, the growth of published literature is getting tremendous large in recent years. The scientists and clinical researchers are facing a big challenge to stay current with the knowledge and to extract hidden information from this sheer quantity of millions of published biomedical literature. The potential one-stop automated solution to this problem is biomedical literature mining. One of the long-standing goals in biology is to discover the disease-causing genes and their specific roles in personalized precision medicine and drug repurposing. However, the empirical approaches and clinical affirmation are expensive and time-consuming. In silico approach using text mining to identify the disease causing genes can contribute towards biomarker discovery. This chapter presents a protocol on combining literature mining and machine learning for predicting biomedical discoveries with a special emphasis on gene-disease relation based discovery. The protocol is presented as a literature based discovery (LBD) pipeline for gene-disease based discovery. The protocol includes our web based tools: (1) DNER (Disease Named Entity Recognizer) for disease entity recognition, (2) BCCNER (Bidirectional, Contextual clues Named Entity Tagger) for gene/protein entity recognition, (3) DisGeReExT (Disease-Gene Relation Extractor) for statistically validated results and visualization, and (4) a newly introduced deep learning based method for association discovery. Our proposed deep learning based method can be generalized and applied to other important biomedical discoveries focusing on entities such as drug/chemical, or miRNA.

BioBERT and Similar Approaches for Relation Extraction

In biomedicine, facts about relations between entities (disease, gene, drug, etc.) are hidden in the large trove of 30 million scientific publications. The curated information is proven to play an important role in various applications such as drug repurposing and precision medicine. Recently, due to the advancement in deep learning a transformer architecture named BERT (Bidirectional Encoder Representations from Transformers) has been proposed. This pretrained language model trained using the Books Corpus with 800M words and English Wikipedia with 2500M words reported state of the art results in various NLP (Natural Language Processing) tasks including relation extraction. It is a widely accepted notion that due to the word distribution shift, general domain models exhibit poor performance in information extraction tasks of the biomedical domain. Due to this, an architecture is later adapted to the biomedical domain by training the language models using 28 million scientific literatures from PubMed and PubMed central. This chapter presents a protocol for relation extraction using BERT by discussing state-of-the-art for BERT versions in the biomedical domain such as BioBERT. The protocol emphasis on general BERT architecture, pretraining and fine tuning, leveraging biomedical information, and finally a knowledge graph infusion to the BERT model layer.